Clinical Trials Browser

Phase 2/3 × INDUSTRY × enfortumab vedotin × Clear all

NCT06493552 2025-04-03

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Phase 2/3 Recruiting

Carcinoma, Transitional Cell